Drug Price Transparency

Name: Drug Price Transparency
Creator: Newspaper Daily
License: United States government work; public domain unless the source record says otherwise.

Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records: 5,000
Last changed: 08/30/2026
Update schedule: 50 16 1 */3 * UTC
Coverage: 01/01/2024–01/01/2024
Method: Methodology

Record	Record Date	Vuga Group	Change Status	Recency Days	Public Significance Score
Cyltezo(Cf) Pen Psoriasis-Uv	01/01/2024	Adalimumab-Adbm	increased	972.23	100
Cyltezo(Cf) Pen	01/01/2024	Adalimumab-Adbm	increased	972.23	100
Cyltezo(Cf) Pen	01/01/2024	Adalimumab-Adbm	increased	972.23	100
Cyltezo(Cf)	01/01/2024	Adalimumab-Adbm	increased	972.23	100
Cyltezo(Cf)	01/01/2024	Adalimumab-Adbm	increased	972.23	100
Cyramza	01/01/2024	Ramucirumab	increased	972.23	100
Cyramza	01/01/2024	Ramucirumab	increased	972.23	100
Cystadrops	01/01/2024	Cysteamine HCl	increased	972.23	100
Cystadrops	01/01/2024	Cysteamine HCl	increased	972.23	100
Cystaran	01/01/2024	Cysteamine HCl	increased	972.23	100
Cystaran	01/01/2024	Cysteamine HCl	increased	972.23	100
Dalvance	01/01/2024	Dalbavancin HCl	increased	972.23	100
Dalvance	01/01/2024	Dalbavancin HCl	increased	972.23	100
Daptomycin	01/01/2024	Daptomycin	increased	972.23	100
Daptomycin	01/01/2024	Daptomycin	increased	972.23	100
Daptomycin	01/01/2024	Daptomycin	increased	972.23	100
Darzalex Faspro	01/01/2024	Daratumumab-Hyaluronidase-Fihj	increased	972.23	100
Darzalex Faspro	01/01/2024	Daratumumab-Hyaluronidase-Fihj	increased	972.23	100
Darzalex	01/01/2024	Daratumumab	increased	972.23	100
Darzalex	01/01/2024	Daratumumab	increased	972.23	100
Dasatinib	01/01/2024	Dasatinib	increased	972.23	100
Dasatinib	01/01/2024	Dasatinib	increased	972.23	100
Dasatinib	01/01/2024	Dasatinib	increased	972.23	100
Daurismo	01/01/2024	Glasdegib Maleate	increased	972.23	100
Daurismo	01/01/2024	Glasdegib Maleate	increased	972.23	100
Decitabine	01/01/2024	Decitabine	increased	972.23	100
Decitabine	01/01/2024	Decitabine	increased	972.23	100
Decitabine	01/01/2024	Decitabine	increased	972.23	100
Decitabine	01/01/2024	Decitabine	increased	972.23	100
Decitabine	01/01/2024	Decitabine	increased	972.23	100
Deferiprone (3 Times A Day)	01/01/2024	Deferiprone	increased	972.23	100
Deferiprone (3 Times A Day)	01/01/2024	Deferiprone	increased	972.23	100
Deferiprone (3 Times A Day)	01/01/2024	Deferiprone	increased	972.23	100
Deflazacort	01/01/2024	Deflazacort	increased	972.23	100
Deflazacort	01/01/2024	Deflazacort	increased	972.23	100
Demser	01/01/2024	Metyrosine	increased	972.23	100
Demser	01/01/2024	Metyrosine	increased	972.23	100
Denavir	01/01/2024	Penciclovir	increased	972.23	100
Denavir	01/01/2024	Penciclovir	increased	972.23	100
Diazepam*	01/01/2024	Diazepam	increased	972.23	100
Diazepam*	01/01/2024	Diazepam	increased	972.23	100
Dichlorphenamide	01/01/2024	Dichlorphenamide	increased	972.23	100
Dichlorphenamide	01/01/2024	Dichlorphenamide	increased	972.23	100
Dificid	01/01/2024	Fidaxomicin	increased	972.23	100
Dificid	01/01/2024	Fidaxomicin	increased	972.23	100
Dihydroergotamine Mesylate*	01/01/2024	Dihydroergotamine Mesylate	increased	972.23	100
Dihydroergotamine Mesylate*	01/01/2024	Dihydroergotamine Mesylate	increased	972.23	100
Dihydroergotamine Mesylate*	01/01/2024	Dihydroergotamine Mesylate	increased	972.23	100
Dihydroergotamine Mesylate*	01/01/2024	Dihydroergotamine Mesylate	increased	972.23	100
Dihydroergotamine Mesylate*	01/01/2024	Dihydroergotamine Mesylate	increased	972.23	100